- All sections
- C - Chemistry; metallurgy
- C12N - Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media
- C12N 15/11 - DNA or RNA fragments; Modified forms thereof
Patent holdings for IPC class C12N 15/11
Total number of patents in this class: 16099
10-year publication summary
669
|
724
|
799
|
1069
|
1173
|
1304
|
1423
|
1541
|
1477
|
496
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of California | 18943 |
451 |
Massachusetts Institute of Technology | 9795 |
278 |
President and Fellows of Harvard College | 5792 |
253 |
The Broad Institute, Inc. | 1584 |
247 |
Alnylam Pharmaceuticals, Inc. | 1066 |
195 |
Ionis Pharmaceuticals, Inc. | 776 |
188 |
University of Massachusetts | 2130 |
153 |
The Board of Trustees of the Leland Stanford Junior University | 6054 |
135 |
The General Hospital Corporation | 4517 |
130 |
The Trustees of the University of Pennsylvania | 4122 |
104 |
Duke University | 2872 |
92 |
City of Hope | 943 |
89 |
CRISPR Therapeutics AG | 361 |
87 |
Inscripta, Inc., FORMERLY Muse Biotechnology, Inc. | 300 |
86 |
The Johns Hopkins University | 5377 |
85 |
University of Vienna | 109 |
85 |
Monsanto Technology LLC | 7905 |
84 |
Pioneer Hi-Bred International, Inc. | 6264 |
78 |
Dicerna Pharmaceuticals, Inc. | 278 |
78 |
Modernatx, Inc. | 1181 |
78 |
Other owners | 13123 |